Private Wealth Management Group’s Arbutus Biopharma ABUS Stock Holding History

Private Wealth Management Group’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.16K	Hold	242	–	–	﹤0.01%	1299
2026 Q2	$1.16K	Hold	242	–	–	﹤0.01%	1272
2026 Q1	$1.09K	Hold	242	–	–	﹤0.01%	1237
2025 Q4	$1.16K	Hold	242	–	–	﹤0.01%	1228
2025 Q3	$1.1K	Hold	242	–	–	﹤0.01%	1260
2025 Q2	$748	Hold	242	–	–	﹤0.01%	1340
2025 Q1	$845	Hold	242	–	–	﹤0.01%	1306
2024 Q4	$792	Hold	242	–	–	﹤0.01%	1351
2024 Q3	$932	Hold	242	–	–	﹤0.01%	1304
2024 Q2	$748	Hold	242	–	–	﹤0.01%	1354
2024 Q1	$625	Hold	242	–	–	﹤0.01%	1395
2023 Q4	$605	Buy	+242	New	+$474	﹤0.01%	1423

Other funds holding ABUS

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Premier Path Wealth Partners Madison, New Jersey $856M AUM 23.55% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Private Wealth Management Group's ABUS Position: Q3 2026 in Review

Private Wealth Management Group held its Arbutus Biopharma (ABUS) position steady in Q3 2026 at 242 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Private Wealth Management Group first reported a position in ABUS in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.16K in Q4 2025. 34 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

Private Wealth Management Group held 242 shares of Arbutus Biopharma worth $1.16K as of Q3 2026.
Private Wealth Management Group left its Arbutus Biopharma share count unchanged in Q3 2026.
Arbutus Biopharma made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #1299 holding.
Private Wealth Management Group first reported a position in Arbutus Biopharma in Q4 2023 and has held it in 12 quarters since.
Private Wealth Management Group's Arbutus Biopharma position peaked at $1.16K in Q4 2025.
34 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.